Exome Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-148,830	Closed	-$1.52M	–	65
2025 Q1	$1.52M	Buy	148,830 +107,618	+261%	+$1.1M	1.35%	36
2024 Q4	$575K	Buy	+41,212	New	+$575K	0.43%	52